AI-Crafted Universal Coronavirus Vaccine Clears Phase I Trial
TL;DR Summary
Researchers at Cambridge used AI to design a pan-coronavirus vaccine, pEVAC-PS, which in a Phase I trial in 39 healthy volunteers appeared safe and elicited cross-reactive immune responses to multiple sarbecoviruses; the team plans Phase II trials and has spun off DIOSynVax to commercialize the AI platform for universal vaccines against threats like flu and Ebola.
Topics:health#artificial-intelligence#coronaviruses#phase-i-trial#science#universal-vaccine#vaccines
- Researchers Are Using AI to Create Vaccines—and It’s Working Gizmodo
- 'World-first' vaccine designed by artificial intelligence BBC
- AI ‘super-antigen’ vaccine could protect against whole families of viruses The Independent
- Universal Sarbeco coronavirus vaccine proves safe in first human trial News-Medical
- New AI-designed vaccine could prevent pandemics and save millions of lives, scientists say Sky News
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
3 min
vs 4 min read
Condensed
92%
667 → 56 words
Want the full story? Read the original article
Read on Gizmodo